Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
Covenant Health, US
Summary
The goal of this clinical trial is to determine if utilizing the Quest AD-Detect blood test, while patient's are hospitalized for a cognitive diagnosis (such as delirium or encephalopathy), will result in an earlier diagnosis of underlying Alzheimer's disease. * Will this blood test have the ability to distinguish between Alzheimer's disease and other causes of cognitive impairment in the inpatient setting? * Neurology Clinic will complete a 6-month post-hospitalization follow up with patients who have had the Quest AD-Detect Alzheimer's Disease blood test completed while they were inpatient to discuss the risk assessment portfolio
Eligibility
- Age range
- 60–90 years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Ages 60 to 90 years old * No prior diagnosis of dementia * Currently hospitalized with cognitive diagnosis, including but no limited to; delirium, encephalopathy, etc. thought to be secondary to a toxic/metabolic state Exclusion Criteria: * Age under 60 years * Prior diagnosis of dementing illness or other organic etiology to cognitive impairment
Interventions
- Diagnostic TestQuest AD-Detect blood test
Blood will be collected and sent for testing using the Quest AD-Detect blood test
Locations (6)
- Cumberland Medical CenterCrossville, Tennessee
- Roane Medical CenterHarriman, Tennessee
- Fort Sanders Regional Medical CenterKnoxville, Tennessee
- Fort Loudon Medical CenterLenoir City, Tennessee
- Methodist Medical CenterOak Ridge, Tennessee
- LeConte Medical CenterSevierville, Tennessee